Back to Search Start Over

Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats.

Authors :
Zhou, Peipei
Yang, Xiaolin
Yang, Zhonglin
Huang, Wenzhe
Kou, Junping
Li, Fei
Source :
Molecules. Apr2019, Vol. 24 Issue 7, p1268-1268. 1p.
Publication Year :
2019

Abstract

Hyperlipidemia is a major component of metabolic syndrome, and regarded as one of the main risk factors causing metabolic diseases. We have developed a therapeutic drug, akebia saponin D (ASD), and determined its anti-hyperlipidemia activity and the potential mechanism(s) of action by analyzing the metabolome and intestinal microbiota. Male Sprague-Dawley rats were fed a high fat diet to induce hyperlipidemia, and then given ASD orally for 8 weeks. Lipid levels in serum were determined biochemically. Metabolites in serum, urine and feces were analyzed by UPLC-Q/TOF-MS, and the structure of the intestinal microbiota was determined by 16S rRNA sequencing. The ASD treatment significantly decreased the levels of TC, TG and LDL-c and increased the serum level of HDL-c. Metabolomics analysis indicated that the ASD treatment mainly impacted seven differential metabolites in the serum, sixteen differential metabolites in the urine and four differential metabolites in feces compared to the model group. The ASD treatment significantly changed eight bacteria at the genus level compared to the model group. In conclusion, ASD treatment can significantly alleviate HFD-induced hyperlipidemia and the hypolipidemic effect of ASD treatment is certainly associated with a systematic change in the metabolism, as well as dynamic changes in the structure of the intestinal microbiota. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14203049
Volume :
24
Issue :
7
Database :
Academic Search Index
Journal :
Molecules
Publication Type :
Academic Journal
Accession number :
135866267
Full Text :
https://doi.org/10.3390/molecules24071268